I think you are right.
Given the low value of the Oz dollar and all the cash AAH has, the offer is very ordinary. They are virtually stealing the pipeline.
The directors appear weak and Australia will lose another promising life science company to the US.
AAH
arana therapeutics limited
Ann: Cephalon Launches Takeover Offer , page-8
Add to My Watchlist
What is My Watchlist?